SYMBIOT III: A Prospective Randomized Trial Evaluating the Symbiot III Covered Stent System In Saphenous Vein Grafts
Study of:
Symbiot III Covered stent Graft; sponsored by Boston Scientific SCIMED
This study is to evaluate the safety and effectiveness of the Symbiot III Covered stent Graft, a new type of stent for patients who have a bypass graft with a blockage. The stent is designed with a stent sandwiched between a graft like material – a graft/stent sandwich. This purpose of the study is to determine if the * Symbiot III Covered stent Graft is superior to regular stents.
- M. Nicholas Burke, MD
- Ivan J. Chavez, MD, FACC
- Timothy D. Henry, MD, FACC
- John R. Lesser, MD, FACC
- Daniel Lips, MD, FACC
- James D. Madison, MD, FACC
- Wesley R. Pedersen, MD, FACC
- Anil K. Poulose, MD, FACC
- Jay H. Traverse, MD, FACC, FAHA
- Yale Wang, MD, FACC, FSCAI
For more information about the interventional cardiology research program at the Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, please contact Carol Stone at 612-863-9124.
|